【结 构 式】 |
【分子编号】21465 【品名】5-(hydroxymethyl)-2-nitrophenol 【CA登记号】 |
【 分 子 式 】C7H7NO4 【 分 子 量 】169.13692 【元素组成】C 49.71% H 4.17% N 8.28% O 37.84% |
合成路线1
该中间体在本合成路线中的序号:(II)A synthesis of the racemic compound was later reported: 3-Hydroxy-4-nitrobenzaldehyde (I) was reduced to the benzyl alcohol (II) with NaBH4 and then converted to diacetate (III) with Ac2O in pyridine. Selective deacetylation of the aryl ester of (III) with KHCO3 in MeOH produced phenol (IV), which was then acylated with acetylsalicyloyl chloride (V) to yield (VI). The catalytic hydrogenation of the nitro group of (VI) in the presence of Raney-Ni was accompanied by migration of the salicyloyl unit to the amino group to yield salicylamide (VII) (accompanied by some byproduct resulting from the cleavage of the phenolic acetate). The resultant mixture of mono- and diacetate was converted to triol (VIII) by hydrolysis in aqueous NaOH. Then, the aminophenol ring of (VIII) was selectively oxidized with Fremy's salt to quinone (IX). Finally, the quinone was treated with H2O2 in the presence of NaHCO3 to furnish the racemic epoxide.
【1】 Matsumoto, N.; Iinuma, H.; Sawa, T.; Takeuchi, T.; Synthesis of anti-rheumatic agent epoxyquinomicin B. Bioorg Med Chem Lett 1998, 8, 21, 2945. |
【2】 Matsumoto, N.; et al.; Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. I. Taxonomy, fermentation, isolation and antimicrobial activities. J Antibiot 1997, 50, 11, 900. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21032 | 3-hydroxy-4-nitrobenzaldehyde | C7H5NO4 | 详情 | 详情 | |
(II) | 21465 | 5-(hydroxymethyl)-2-nitrophenol | C7H7NO4 | 详情 | 详情 | |
(III) | 21466 | 5-[(acetoxy)methyl]-2-nitrophenyl acetate | C11H11NO6 | 详情 | 详情 | |
(IV) | 21467 | 3-hydroxy-4-nitrobenzyl acetate | C9H9NO5 | 详情 | 详情 | |
(V) | 16900 | 2-(chlorocarbonyl)phenyl acetate; Acetylsalicyloyl chloride | 5538-51-2 | C9H7ClO3 | 详情 | 详情 |
(VI) | 21469 | 5-[(acetoxy)methyl]-2-nitrophenyl 2-(acetoxy)benzoate | C18H15NO8 | 详情 | 详情 | |
(VII) | 21470 | 4-[[2-(acetoxy)benzoyl]amino]-3-hydroxybenzyl acetate | C18H17NO6 | 详情 | 详情 | |
(VIII) | 21471 | 2-hydroxy-N-[2-hydroxy-4-(hydroxymethyl)phenyl]benzamide | C14H13NO4 | 详情 | 详情 | |
(IX) | 21472 | 2-hydroxy-N-[4-(hydroxymethyl)-3,6-dioxo-1,4-cyclohexadien-1-yl]benzamide | C14H11NO5 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XVI)Synthesis of intermediates (XX) and (XXIII): Coupling of methyl L-lactate (XII) with morpholine in presence of NaH yields amide (XIII) which is tosylated by means of NaH and p-TsCl in THF to afford (XIV). Reduction of carboxylic acid (XV) in DCE with B(OCH3)3, boron trifluoride diethyl etherate and BH3·pyr complex provides alcohol (XVI) which is then condensed with (XIV) in presence of K2CO3 in DMF to yield (XVII). Mesylation of (XVII) with MsCl in presence of Et3N in CH2Cl2 affords (XVIII), which reacts with potassium phthalimide (C) in DMF to give (XIX). Hydrogenation of phthalimide (XIX) with H2 over Pd/C in DMF provides derivative (XX). The treatment of (XIX) with NH2NH2 and p-TsOH gives amine (XXI), which is protected with di-t-butyl-dicarbonate to yield (XXII). Finally (XXIII) is obtained by reduction of the nitro moiety of (XXII) with H2 over Pd/C in EtOAc.
【1】 Katayama, S.; Kishimoto, H.; Ae, N.; Nagata, R. (Sumitomo Pharmaceuticals Co., Ltd.); Tricyclic indole-2-carboxylic acid cpd. used as NMDA receptor antagonist. WO 0056711 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XII) | 17075 | propionic acid, 2-hydroxy-, methyl ester, (S)-; methyl (2S)-2-hydroxypropanoate | 27871-49-4 | C4H8O3 | 详情 | 详情 |
(XIII) | 41498 | (2S)-2-hydroxy-1-(4-morpholinyl)-1-propanone | C7H13NO3 | 详情 | 详情 | |
(XIV) | 41499 | (1S)-1-methyl-2-(4-morpholinyl)-2-oxoethyl 4-methylbenzenesulfonate | C14H19NO5S | 详情 | 详情 | |
(XV) | 41500 | 3-hydroxy-4-nitrobenzoic acid | 619-14-7 | C7H5NO5 | 详情 | 详情 |
(XVI) | 21465 | 5-(hydroxymethyl)-2-nitrophenol | C7H7NO4 | 详情 | 详情 | |
(XVII) | 41501 | (2R)-2-[5-(hydroxymethyl)-2-nitrophenoxy]-1-(4-morpholinyl)-1-propanone | C14H18N2O6 | 详情 | 详情 | |
(XVIII) | 41502 | (2R)-2-[5-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-2-nitrophenoxy]-1-(4-morpholinyl)-1-propanone | C17H24N2O6S | 详情 | 详情 | |
(XIX) | 41503 | 2-(3-[[(1R)-1-methyl-2-(4-morpholinyl)-2-oxoethyl]oxy]-4-nitrobenzyl)-1H-isoindole-1,3(2H)-dione | C22H21N3O7 | 详情 | 详情 | |
(XX) | 41506 | 2-(4-amino-3-[[(1R)-1-methyl-2-(4-morpholinyl)-2-oxoethyl]oxy]benzyl)-1H-isoindole-1,3(2H)-dione | C22H23N3O5 | 详情 | 详情 | |
(XXI) | 41504 | (2R)-2-[5-(aminomethyl)-2-nitrophenoxy]-1-(4-morpholinyl)-1-propanone | C14H19N3O5 | 详情 | 详情 | |
(XXII) | 41505 | tert-butyl 3-[[(1R)-1-methyl-2-(4-morpholinyl)-2-oxoethyl]oxy]-4-nitrobenzylcarbamate | C19H27N3O7 | 详情 | 详情 | |
(XXIII) | 41507 | tert-butyl 4-amino-3-[[(1R)-1-methyl-2-(4-morpholinyl)-2-oxoethyl]oxy]benzylcarbamate | C19H29N3O5 | 详情 | 详情 | |
(C) | 27890 | Potassium phthalimide | 1074-82-4 | C8H4KNO2 | 详情 | 详情 |